PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Medical Oncology Unit, Department of Clinical and Molecular Medicine, Sant\'Andrea Hospital, Sapienza University, Rome, Italy.\', \'Department of Radiological, Oncological and Anatomo-Pathological Sciences, Policlinico Umberto I, Sapienza - Università di Roma, Rome, Italy.\', \'Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/tbj.14204
?:hasPublicationType
?:journal
  • The breast journal
is ?:pmid of
?:pmid
?:pmid
  • 33677841
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all